Stock options program for executive management of Nobel Biocare

Stock options program for executive management of Nobel Biocare In conjunction with the public announcement on June 29, 1998 of Nobel Biocare's acquisition of the American dental implant company, Steri-Oss Inc., Nobel Biocare's largest shareholder (Investment AB Bure) and Steri-Oss largest shareholder (Brown Brothers Harriman & Co.) presented a stock options program comprising 380,000 options for more than thirty top executives at Nobel Biocare AB. The first phase of this program was announced in July 1998. The second options allotment was issued by Brown Brothers Harriman & Co. in January 1999 with a total of 138,000 options to some 20 top executives. The transactions have taken place according to generally accepted market principles and an options assessment made by Enskilda Securities. Each option costs SEK 19.00. The terms were based on the market conditions of January 21- 27, 1999 during which the average price paid for a Nobel Biocare share was SEK 116. The date of maturity for the options is May 1, 2003 and the redemption price is SEK 140. Gothenburg, Sweden, February 17, 1999 NOBEL BIOCARE AB For further information please contact: Jan Sundqvist, Vice President Business Development, Nobel Biocare AB, telephone +1 714 299 8580 or Mikael Kromli, CFO, Nobel Biocare AB, telephone +46 31 81 89 80. Nobel Biocare is an innovative, medical devices company, whose core business comprises dental implants and dental prosthetics. The company's product ® ® systems for dental implants, Brånemark System and Steri-Oss , are world leaders and have a global market share of around 40%. ® The company's other product line, Procera , is a unique, patented CAD/CAM- based process for the industrial production of dental prosthetics. The system has been launched very successfully in North America and parts of Europe. Nobel Biocare has around 1,000 employees and, in 1997, turnover totalled SEK 1,068 million for Nobel Biocare and approximately SEK 300 million for the recently-acquired American dental implant company Steri-Oss Inc. The company's headquarters are located in Gothenburg, Sweden, while production takes place in Sweden and the USA. Nobel Biocare has its own sales companies in some 20 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/02/17/19990701BIT00430/bit0001.doc http://www.bit.se/bitonline/1999/02/17/19990701BIT00430/bit0002.pdf